how to discuss immunotherapy as a treatment option with lung cancer patients
Published 7 years ago • 93 plays • Length 0:45Download video MP4
Download video MP3
Similar videos
-
4:15
the toxicities associated with immunotherapy in lung cancer patients
-
1:54
balancing the benefits and costs of immunotherapy in the treatment of lung cancer
-
3:39
what is durvalumab’s future as a treatment option in lung cancer?
-
1:31
the nurse's perspective on caring for lung cancer patients receiving immunotherapy
-
1:30
immunotherapy in second-line treatment of non-small cell lung cancer
-
2:24
advancing lung cancer therapy: from palliative chemotherapy to immunotherapy
-
4:37
treating pd-l1-positive nsclc with immunotherapy alone vs chemoimmunotherapy
-
1:24
personalized cancer treatment with er inhibition strategies for nsclc
-
3:24
novel immunotherapy agents on the horizon for lung cancer
-
3:02
neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer
-
2:46
unanswered questions in treating lung cancer with immunotherapy
-
5:02
going beyond pd-l1 testing for lung cancer immunotherapy
-
4:00
chemotherapy and immunotherapy: to combine or not to combine?
-
3:31
the use of immunotherapy as a first-line therapy for bladder cancer
-
3:04
the nurse's perspective on looking after lung cancer patients receiving immunotherapy
-
1:19
developments in immunotherapy for lung cancer
-
6:57
updates in lung cancer: neoadjuvant immunotherapy and targeted therapies
-
3:43
immunotherapy for operable lung cancer
-
3:46
lds1 as a potential target in sclc